CDC Releases First Estimate of Human Papillomavirus-Associated Cancer Data

CDC Releases First Estimate of Human Papillomavirus-Associated Cancer Data

ArticlePress release
Health & Wellness
Diseases & Conditions
Contributed byLester Fahrner, MDMar 31, 2020

CDC Releases First Estimate of Human Papillomavirus-Associated Cancer Data

About 25,000 cases occurred annually during 1998-2003

Twenty-five thousand cases of human papillomavirus (HPV)-associated cancers occurred in 38 states and the District of Columbia annually during 1998-2003, according to studies conducted by CDC. The report, "Assessing the Burden of Human Papillomavirus (HPV)-Associated Cancers in the United States (ABHACUS)," was published online and appears in the Nov. 15, 2008, supplement edition of Cancer.

"These estimates of HPV-associated cancers were collected prior to the development of the HPV vaccine. This gives us baseline data to measure the impact of HPV vaccine and cervical cancer screening programs in reducing the incidence of cervical cancer and other HPV-associated cancers and precancers," said Mona Saraiya, M.D., M.P.H., medical officer in CDC's Division of Cancer Prevention and Control and coordinator of the studies.

This first analysis of the largest, most comprehensive assessment of HPV-associated cancer data to date in the United States used cancer registry data from CDC’s National Program of Cancer Registries and the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program. 

The top HPV-associated cancer sites were cervix, oral cavity and oropharynx, anus, vulva, penis, and vagina. HPV is the name of a group of viruses that includes more than 100 different types. More than 30 of these HPV types can be sexually transmitted.  Most people with HPV infection do not develop symptoms or health problems. Some HPV types can cause cervical cancer and other less common cancers, such as cancer of the vulva, vagina, anus, and penis. Other HPV types can cause genital warts.

Significant findings include:

Age-adjusted rates are presented in parentheses where appropriate and are per 100,000 persons.

CERVIX:  More HPV-associated cancers occur in the cervix than any other site – about 10,800 per year. The incidence rate of cervical cancer was 8.9 women during 1998-2003.  Black and Hispanic women had higher rates of cervical cancer (12.6 and 14.2, respectively) than white and non-Hispanic women (both 8.4). 

ORAL CAVITY AND OROPHARYNX: Cancers in some areas of the head and neck (oral cavity and oropharynx) are more likely to be HPV-associated than other areas. There were nearly 7,400 potentially HPV-associated cancers of the oral cavity and oropharynx per year – nearly 5,700 among men and about 1,700 among women. Incidence rates for a subset of the HPV-associated cancers of the oral cavity and oropharynx (cancers of the tonsil and cancers of the base of the tongue) were higher in men than women. These cancers significantly increased (3.0 percent) per year during the reporting period. 

ANAL: There were more than 3,000 HPV-associated anal cancers per year – about 1,900 in women and 1,100 in men. HPV-associated anal cancer occurs more frequently among women (1.5) compared to men (1.0).  Whites had the highest rates among women (1.6), while blacks had the highest rates among men (1.2).

VULVAR: There were about 2,300 new cases of vulvar cancer each year during the study period.  In contrast to cervical cancer, white women (1.8) had higher rates of vulvar cancer than black (1.3) and Asian/Pacific Islander (0.4) women.

PENILE: Penile cancer is relatively rare, striking about 800 men each year.  Incidence rates were higher among Hispanic men (1.3) than non-Hispanic men (0.8).  

VAGINAL: About 600 women a year developed vaginal cancers. Incidence rates were higher among black women than white women (0.7 and 0.4, respectively), and incidence rates were lowest among Asian/Pacific Islander women (0.3).

Women with a history of cervical cancer have an increased risk of developing subsequent in situ (non-invasive) cancers of the vagina and vulva, as well as invasive cancers of the vagina, vulva, and rectum.

The Cancer supplement chapters also focus on disparities of HPV-associated cancers, how CDC and state and local programs address such disparities, background of the HPV vaccine, the economic impact of HPV-associated cancer mortality, the burden of cervical cancers in specific states with a high burden of disease, and surveillance of behavioral risk factors related to these cancers. These studies were conducted by scientists at CDC and several researchers at other organizations including the National Cancer Institute, the American Cancer Society, state cancer registry staff, and academic institutions.

For the online article, go to http://www3.interscience.wiley.com/journal/121498429/issue. For information on gynecologic cancers please visit www.cdc.gov/cancer/gynecologic.  For information on cervical cancer screening for low income, uninsured, and underinsured women, please visit http://www.cdc.gov/cancer/nbccedp/. For information on how men are affected by HPV-associated cancer, please visit http://www.cdc.gov/std/hpv/stdfact-hpv-and-men.htm.

###

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

Was this article helpful

On the Article

Lester Fahrner, MD picture
Approved by

Lester Fahrner, MD

Chief Medical Officer, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!